Völpel S, Lichtenauer I, Eichler J
Arzneimittelforschung. 1979;29(2):334-6.
The respiratory stimulatory effect of 3'chloro-2'-(N-methyl-N-[(morpholino-carbonyl)methyl]-aminomethyl)benzanilide hydrochloride (fominoben, Noleptan, PB 89) on the respiratory-depressing effect of pethidine/promethazine was investigated. In addition a double blind study was carried out on 36 patients with fominoben or placebo after pethidine/promethazine. To evaluate respiratory function the vital capacity, Tiffeneau-value, volume of inhaled air/s, maximum breathing capacity, as well as the blood gas values (pO2, pCO2 and pH according to Astrup) were measured. The results can be summarised as follows: 1. As was to be expected the combination pethidine/promethazine caused a deterioration in all parameters. This negative effect could be partially improved by fominoben. 2. A marked difference in the volume of inhaled air/s could be seen after fominoben in comparison to the placebo. The remaining differences were insignificant. 3. Pethidine/promethazine had, as had been expected, a significant effect on pain symptoms, but no analgetic effect could be shown for fominoben.
研究了盐酸3'-氯-2'-(N-甲基-N-[(吗啉代羰基)甲基]-氨甲基)苯甲酰苯胺(吗啉苯甲酰苯胺、诺来替坦、PB 89)对哌替啶/异丙嗪呼吸抑制作用的呼吸刺激效应。此外,对36例接受哌替啶/异丙嗪治疗后使用吗啉苯甲酰苯胺或安慰剂的患者进行了双盲研究。为评估呼吸功能,测量了肺活量、蒂芬诺值、每秒吸入空气量、最大呼吸容量以及血气值(根据阿斯特鲁普法测量的pO2、pCO2和pH)。结果总结如下:1. 正如预期的那样,哌替啶/异丙嗪组合导致所有参数恶化。吗啉苯甲酰苯胺可部分改善这种负面影响。2. 与安慰剂相比,使用吗啉苯甲酰苯胺后每秒吸入空气量有明显差异。其余差异不显著。3. 正如预期的那样,哌替啶/异丙嗪对疼痛症状有显著影响,但未显示吗啉苯甲酰苯胺有镇痛作用。